Brief: Compugen As Of Sept. 30, 2023, Cash, Cash Equivalents And Cash Investments Were About $57.5 Million
Nov 7 (Reuters) - Compugen Ltd CGEN.TA :
* COMPUGEN LTD: AS OF SEPTEMBER 30, 2023, CASH, CASH
EQUIVALENTS
AND CASH INVESTMENTS WERE APPROXIMATELY $57.5 MILLION
* COMPUGEN LTD: EXPECTS ITS EXISTING CASH AND CASH RELATED
BALANCES TO BE SUFFICIENT TO FUND ITS CURRENT OPERATING PLAN AT
LEAST THROUGH END OF 2024
* COMPUGEN LTD: NET LOSS FOR Q3 ENDED SEPTEMBER 30, 2023 WAS
APPROXIMATELY $9.9 MILLION, OR $0.11 PER BASIC AND DILUTED SHARE
Source text for Eikon: ID:nPn3MNNrla
Further company coverage: CGEN.TA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Compugen
See all newsIsrael's Compugen Q2 revenue more than doubles, net loss narrows
Brief: Compugen Announces The Appointment Of Michele Holcomb, Ph.D., To Its Board Of Directors
Brief: Compugen Monetizes Portion Of Rilvegostomig Future Royalties To Astrazeneca For Up To $90 Million
Brief: Compugen Announces First Patient Dosed In Com701 Global Platform Trial In Platinum Sensitive Ovarian Cancer
Brief: Compugen Announces Leadership Transitions Effective September 2025